Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hemodialysis I: Introduction

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

Cardiac Catheterization II: Right Heart Catheterization

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2020

Same author

Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2018

Same author

Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Clinical journal of the American Society of Nephrology : CJASN·2017

Same author

Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.

Lancet (London, England)·2016

Same author

HeRO graft versus lower extremity grafts in hemodialysis patients with long standing renal failure.

The journal of vascular access·2016

Same author

Prospective multicenter study with a 1-year analysis of a new vascular graft used for early cannulation in patients undergoing hemodialysis.

Journal of vascular surgery·2015

Same journal

Management decisions for patients with chronic limb-threatening ischemia in 2026.

Seminars in vascular surgery·2026

Same journal

A critical analysis of the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) and the European Carotid Surgery Trial (ECST)-2.

Seminars in vascular surgery·2026

Same journal

Operationalizing patient and stakeholder engagement in high-acuity trials: Lessons from IMPROVE-AD.

Seminars in vascular surgery·2026

Same journal

Lost to follow-up: A narrative review of socioeconomic, psychosocial, and systemic barriers to aortic dissection surveillance.

Seminars in vascular surgery·2026

Same journal

Regulatory oversight, innovation, and access in aortic dissection care: The evolving roles of the US Food and Drug Administration and Centers for Medicare & Medicaid Services.

Seminars in vascular surgery·2026

Same journal

What is the best thoracic endovascular aortic repair landing zone for Type B aortic dissection?

Seminars in vascular surgery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

HeRO Vascular Access Device.

Marc H Glickman¹

¹Vascular and Transplant Specialists, Virginia Beach, VA 23452, USA. MHGLICKM@sentara.com

Seminars in Vascular Surgery

|September 6, 2011

Summary

This summary is machine-generated.

The HeRO Vascular Access Device offers a safer alternative to tunneled dialysis catheters (TDC) for chronic hemodialysis, significantly reducing infectious complications and mortality risks. This device is a preferred option for catheter-dependent patients needing long-term vascular access.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: May 29, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

Nephrology
Vascular Surgery
Infectious Diseases

Background:

Chronic hemodialysis often requires vascular access, with tunneled dialysis catheters (TDC) posing significant risks.
TDC use is linked to high rates of infectious complications and increased patient mortality.
Alternative vascular access methods are crucial for improving patient outcomes in chronic hemodialysis.

Purpose of the Study:

To evaluate the HeRO Vascular Access Device as an alternative to TDC for chronic hemodialysis.
To compare the incidence of infectious complications between the HeRO device and TDC.
To assess the efficacy and safety of the HeRO device in catheter-dependent patients.

Main Methods:

Retrospective analysis of patients undergoing chronic hemodialysis with either TDC or the HeRO Vascular Access Device.
Comparison of infectious complication rates, secondary patency, and device placement success.
Evaluation of patient outcomes and mortality associated with each access type.

Main Results:

The HeRO Vascular Access Device demonstrated significantly lower infectious complication rates compared to TDC.
Secondary patency for the HeRO device was comparable to prosthetic accesses.
Successful placement of the HeRO device was achieved in over 90% of catheter-dependent patients.

Conclusions:

The HeRO Vascular Access Device is a safer and effective alternative to TDC for chronic hemodialysis.
HeRO device use is associated with reduced infectious complications and favorable patency rates.
Chronic hemodialysis via the HeRO Device is preferable to TDC, especially when other access options are limited.